医薬品セクターWeekly: 7月27-31日: 4-6月決算. Sat Aug 01 2026

Research evidence excerpt

医薬品セクターWeekly: 7月27-31日: 4-6月決算. Sat Aug 01 2026

earing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of JPMSAL only to

"wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be found by visiting

https://www.jpmm.com/research/disclosures. J.P. Morgan seeks to cover companies of relevance to the domestic and international investor base

across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation sizes. If applicable, in the course of

conducting public side due diligence on the subject company(ies), the Research Analyst team may at times perform such diligence through corporate

engagements such as site visits, discussions with company representatives, management presentations, etc. Research issued by JPMSAL has been

prepared in accordance with J.P. Morgan Australia˖s Research Independence Policy which can be found at the following link: J.P. Morgan Australia -

Research Independence Policy.

Brazil: Banco J.P. Morgan S.A. is regulated by the Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Ombudsman J.P.

Morgan: 0800-7700847 / 0800-7700810 (For Hearing Impaired) / ouvidoria.jp.morgan@jpmchase.com.

Canada: J.P. Morgan Securities Canada Inc. is a registered investment dealer, regulated by the Canadian Investment Regulatory Organization and the

Ontario Securities Commission and is the participating member on Canadian exchanges. This material is distributed in Canada by or on behalf of

J.P.Morgan Securities Canada Inc.

Chile: Inversiones J.P. Morgan Limitada is an unregulated entity incorporated in Chile.

China: J.P.